Kymera Therapeutics KYMR
NASDAQ KYMR
$134.67 -0.17 (-0.13%)
As of: Nov 12, 2026 · 9:31 AM EST

Kymera Therapeutics (KYMR) Gains (Losses) on Sale of Assets & Investments (2020 - 2026)

Updated

Analysis

Kymera Therapeutics (KYMR) Gains (Losses) on Sale of Assets & Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Kymera Therapeutics 11.66 Bn 8.50 Bn - -7.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -7.58 Mn
Jun 30, 2026 -2.96 Mn
Mar 31, 2026 -5.99 Mn
Dec 31, 2025 299,000.00
Sep 30, 2025 1.22 Mn
Jun 30, 2025 337,000.00
Mar 31, 2025 1.43 Mn
Dec 31, 2024 -3.42 Mn
Sep 30, 2024 4.03 Mn
Jun 30, 2024 -322,000.00
Mar 31, 2024 -1.23 Mn
Dec 31, 2023 1.90 Mn
Sep 30, 2023 1.19 Mn
Jun 30, 2023 -597,000.00
Mar 31, 2023 1.91 Mn
Dec 31, 2022 964,000.00
Sep 30, 2022 -1.93 Mn
Jun 30, 2022 -767,000.00
Mar 31, 2022 -2.56 Mn
Dec 31, 2021 -514,000.00
API Access

Kymera Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=KYMR&period=max&api_key=YOUR_API_KEY